{
    "nct_id": "NCT05970341",
    "official_title": "\"Kidney Health: Eat Well, Live Well\": A Program to Reduce Kidney Injury and Early CKD Progression Through Nutrition & Empathetic Support From a Health Partner",
    "inclusion_criteria": "* Adult (18 years of age or older)\n* Primary care visit at either one of the three partner clinics from Harris Health [Smith Clinic, Harris Health Outpatient Center (located on the LBJ campus), or Martin Luther King Jr. Health Center (MLK)] and a primary care patient within Harris Health System\n* Have had at least 1 visit in the past 18 months with prior history in the clinic (i.e., not first visit)\n* Diagnosis of CKD (Stage 2, 3a, and 3b) as defined by estimated Glomerular Filtration Rate (eGFR) ≥ 30 and <90 mL/min/1.73 m2 OR CDK 1 or undiagnosed with urine Albumin Creatinine Ratio ≥ 30 mg/g\n* Within the past 12 months, the most current serum K+ ≤ 4.6 mEq/L\n* English or Spanish speaking\n* Ability to participate in the program at least 6 months\n* Ability to clean, prepare, refrigerate/freeze food products that are given to them\n* Have access to receive SMS text messages\n* Location of preferred produce bag delivery within an available delivery zone\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* CKD 4, ESRD or on dialysis.\n* Taking certain medications chronically (more than twice a week for 90 days) that may interfere with K+ metabolism (such as non-steroidal anti-inflammatory drugs (NSAIDs), as self-reported during enrollment screening\n* Taking mineralocorticoid receptor antagonists\n* Taking Warfarin\n* Diagnosis of any specific kidney conditions (such as polycystic kidney disease, glomerulonephritis, Lupus associated with Nephritis, Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)) that would contraindicate study participation as determined by physician\n* Medical history of organ transplant that would contraindicate study participation as determined by physician\n* Received immunotherapy for primary or secondary kidney disease within 6 months prior to enrolment\n* Diagnostic of heart failure conditions Class IV in the New York Heart Association (NYHA) functional classification\n* Had myocardial infarction, unstable angina, stroke, or transient ischemic attack (TIA) within 12 weeks prior to enrolment\n* Had coronary revascularization (PCI, CABG) or valvular repair within 12 weeks prior to enrolment\n* On active hospice care as self-reported during enrollment screening\n* Diagnosis of active malignancy requiring treatment that would contraindicate study participation as determined by physician\n* Has decompensated cirrhosis as determined by physician\n* Cognitive impairment that would contraindicate study participation as self-reported during enrollment screening",
    "miscellaneous_criteria": ""
}